ETERNYGEN

eternygen-logo

Eternygen is a Berlin based start up founded in June 2012 focusing on research and development of innovative drugs using a network of renowned scientists and contract research organizations. The main focus of Eternygenโ€™s development and core competences of its founders are research and development of new drugs for dietary-related metabolic diseases with dramatically increasing prevalences in the last decades. Eternygenโ€™s research addresses the sodium coupled citrate transporter NaCT which is a key regulator of lipid metabolism involved in the pathogenesis of fatty liver, diabetes and obesity. Companyโ€™s emphasis is the development of a safe and effective drug for treatment of these widespread diseases via targeted adjustment of underlying metabolic failure.

#SimilarOrganizations #People #Financial #Website #More

ETERNYGEN

Social Links:

Industry:
Biotechnology Health Care Health Diagnostics

Founded:
2012-06-01

Address:
Berlin, Berlin, Germany

Country:
Germany

Website Url:
http://www.eternygen.de

Total Employee:
1+

Status:
Active

Contact:
49 30 1207 6983 0

Total Funding:
8 M EUR

Technology used in webpage:
Viewport Meta IPhone / Mobile Compatible SPF SSL By Default Apple Mobile Web Clips Icon WordPress Font Awesome Apache Wordpress Plugins Sitelinks Search Box


Similar Organizations

not_available_image

Amadeite

Amadeite offers research and development of active ingredients, including algae bio-resources to find natural alternatives.

knopp-biosciences-logo

Knopp Biosciences

Knopp Neurosciences is a drug discovery and development company working on treatments for neurological disorders.


Current Advisors List

jens-jordan_image

Jens Jordan Advisor @ Eternygen
Advisor

andreas-birkenfeld_image

Andreas Birkenfeld Advisor @ Eternygen
Advisor

Current Employees Featured

grit-zahn_image

Grit Zahn
Grit Zahn Head of Research @ Eternygen
Head of Research
2013-09-01

andreas-birkenfeld_image

Andreas Birkenfeld
Andreas Birkenfeld Founder @ Eternygen
Founder

jens-jordan_image

Jens Jordan
Jens Jordan Co-Founder @ Eternygen
Co-Founder
2012-01-01

marco-janezic_image

Marco Janezic
Marco Janezic CEO & Co founder @ Eternygen
CEO & Co founder
2012-09-01

Founder


andreas-birkenfeld_image

Andreas Birkenfeld

jens-jordan_image

Jens Jordan

marco-janezic_image

Marco Janezic

Investors List

evotec-inc_image

Evotec

Evotec investment in Series A - Eternygen

epidarex-capital_image

Epidarex Capital

Epidarex Capital investment in Series A - Eternygen

vc-fonds-technologie-berlin_image

VC Fonds Technologie Berlin

VC Fonds Technologie Berlin investment in Series A - Eternygen

Official Site Inspections

http://www.eternygen.de

  • Host name: wp679.webpack.hosteurope.de
  • IP address: 5.175.14.201
  • Location: Germany
  • Latitude: 51.4476
  • Longitude: 7.0122
  • Timezone: Europe/Berlin

Loading ...

More informations about "Eternygen"

about_us - en - Eternygen GmbH

Eternygen is a Berlin based start up founded in June 2012 focusing on research and development of innovative drugs using a network of renowned scientists and contract research organizations. The main focus of Eternygenโ€™s development โ€ฆSee details»

Eternygen - Crunchbase Company Profile & Funding

Eternygen is a Berlin based start up founded in June 2012 focusing on research and development of innovative drugs using a network of renowned scientists and contract research โ€ฆSee details»

Eternygen 2025 Company Profile: Valuation, Funding & Investors

Eternygen General Information Description. Developer of a novel therapy intended to offer treatment for metabolic diseases. The company's therapy offers small molecule inhibitors for โ€ฆSee details»

Eternygen GmbH - The Org

Eternygen is a Berlin based start up founded in June 2012 focusing on research and development of innovative drugs using a network of renowned scientists and contract research โ€ฆSee details»

Eternygen Company Profile - Office Locations, Competitors, โ€ฆ

Eternygen is focusing on research and development of innovative drugs using a network of renowned scientists and contract research organizations. The main focus of Eternygen´s โ€ฆSee details»

Eternygen GmbH Company Profile | Berlin, Berlin, Germany

Find company research, competitor information, contact details & financial data for Eternygen GmbH of Berlin, Berlin. Get the latest business insights from Dun & Bradstreet.See details»

Eternygen - Overview, News & Similar companies | ZoomInfo.com

Oct 27, 2020 Eternygen contact info: Phone number: +49 3012076983 Website: www.eternygen.de What does Eternygen do? Eternygen is a Berlin based Biotech Company โ€ฆSee details»

eternygen - Eternygen GmbH

Eternygen GmbH 2025 Wir verwenden Cookies (auch von Drittanbietern), um Informationen über die Nutzung unserer Websites durch die Besucher zu sammeln. Diese Cookies helfen uns โ€ฆSee details»

Eternygen GmbH - F6S

Eternygen GmbH is a Berlin-based drug development company founded in 2012 focusing on the development of innovative treatments for diabetes (Type-2), obesity, fatty liver (NASH) and โ€ฆSee details»

Eternygen (Eternygen GmbH) - startbase.com

Headquarter: Berlin, DE; Official Website: eternygen.de; On Social Media: Legal Entity: Eternygen GmbH Location: Berlin Overview Company Funding Product Team News Is this your โ€ฆSee details»

Eternygen GmbH - Berlin, Deutschland - bionity.com

Die Eternygen GmbH mit Sitz in Berlin wurde im Jahr 2012 gegründet und erforscht und entwickelt innovative Arzneimittel in Zusammenarbeit mit einem Netzwerk aus international โ€ฆSee details»

Eternygen GmbH Information - RocketReach

Eternygen is a Berlin based start up founded in June 2012 focusing on research and development of innovative drugs using a network of renowned scientists and contract research โ€ฆSee details»

founders - en - Eternygen GmbH

Managing Director and co-founder of Eternygen, CEO and Founding Partner Blue Ribbon Partners, Managing Director Life Science Factory Göttingen, Associate of the Creative โ€ฆSee details»

Eternygen company information, funding & investors | Dealroom.co

Jun 1, 2012 Eternygen, focuse on research and development of innovative drugs. Here you'll find information about their funding, investors and team. ... eternygen.de. Launch date. Jun โ€ฆSee details»

Eternygen (Eternygen GmbH) - startbase.de

Eternygen präsentiert Daten, die eine INDY-Inhibition als neue therapeutische Option für NASH aufzeigen Quelle: DGAP 09.01.2017 09:00 Eternygen GmbH schließt 8 Millionen Euro Serie-A โ€ฆSee details»

Eternygen GmbH Overview | SignalHire Company Profile

Eternygen is a Berlin based start up founded in June 2012 focusing on research and development of innovative drugs using a network of renowned scientists and contract research โ€ฆSee details»

about_us - Eternygen GmbH

EN / DE; about_us. ÜBER UNS . Die Eternygen GmbH mit Sitz in Berlin wurde im Jahr 2012 gegründet und erforscht und entwickelt innovative Arzneimittel in Zusammenarbeit mit einem โ€ฆSee details»

Eternygen GmbH Company Information - Funding, Investors, and โ€ฆ

Track over 71,000 companies. Discover Fast-growing Global startups. Seedtable uses technology and people to track over 71,000 companies to help you find the right ones to partner with.See details»

eternygen - en - Eternygen GmbH

DE / EN; eternygen โ€“ en โ€œA new paradigm for treating metabolic diseases.โ€ ABOUT US. Eternygen is a Berlin based start up founded in June 2012 focusing on research and โ€ฆSee details»

research & development - en - Eternygen GmbH

Thus, Eternygen´s proprietary molecules have been shown a therapeutic effect on glucose metabolism and hepatic lipid oxidation in a diet induced obesity model in mice. Furthermore, โ€ฆSee details»

linkstock.net © 2022. All rights reserved